Literature DB >> 9357975

Expression of protein-tyrosine phosphatases in the major insulin target tissues.

K Norris1, F Norris, D H Kono, H Vestergaard, O Pedersen, A N Theofilopoulos, N P Møller.   

Abstract

Protein-tyrosine phosphatases (PTPs) are key regulators of the insulin receptor signal transduction pathway. We have performed a detailed analysis of PTP expression in the major human insulin target tissues or cells (liver, adipose tissue, skeletal muscle and endothelial cells). To obtain a representative picture, all tissues were analyzed by PCR using three different primer sets corresponding to conserved regions of known PTPs. A total of 24 different PTPs were identified. A multiprobe RNase protection assay was developed to obtain a semiquantitative measure of the expression levels of selected PTPs. Surprisingly, PTP-LAR, previously suggested to be a major regulator of the insulin receptor tyrosine kinase, was expressed in extremely low levels in skeletal muscle, whereas the related receptor-type PTP-sigma and PTP-alpha were expressed in relatively high levels in all four tissues. The low levels of LAR PTP mRNA in skeletal muscle were further confirmed by Northern blot analysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357975     DOI: 10.1016/s0014-5793(97)01133-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Extracellular domain dependence of PTPalpha transforming activity.

Authors:  Barbara Tremper-Wells; Ross J Resnick; Xinmin Zheng; Leslie J Holsinger; David Shalloway
Journal:  Genes Cells       Date:  2010-06-07       Impact factor: 1.891

Review 2.  Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance.

Authors:  Elaine Xu; Michael Schwab; André Marette
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

3.  Variants of insulin-signaling inhibitor genes in type 2 diabetes and related metabolic abnormalities.

Authors:  Carlo de Lorenzo; Annalisa Greco; Teresa Vanessa Fiorentino; Gaia Chiara Mannino; Marta Letizia Hribal
Journal:  Int J Genomics       Date:  2013-05-23       Impact factor: 2.326

4.  The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system.

Authors:  Maria Lodeiro; Begoña O Alén; Carlos S Mosteiro; Daniel Beiroa; Rubén Nogueiras; Marily Theodoropoulou; María Pardo; Rosalía Gallego; Yolanda Pazos; Felipe F Casanueva; Jesus P Camiña
Journal:  Mol Biol Cell       Date:  2011-09-07       Impact factor: 4.138

5.  Adaptively inferring human transcriptional subnetworks.

Authors:  Debopriya Das; Zaher Nahlé; Michael Q Zhang
Journal:  Mol Syst Biol       Date:  2006-06-06       Impact factor: 11.429

6.  Deletion of Protein Tyrosine Phosphatase 1B (PTP1B) Enhances Endothelial Cyclooxygenase 2 Expression and Protects Mice from Type 1 Diabetes-Induced Endothelial Dysfunction.

Authors:  David J Herren; David J Herre; J Blake Norman; Ruchi Anderson; Michel L Tremblay; Anne-Cecile Huby; Eric J Belin de Chantemèle
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

7.  The tyrosine phosphatase SHP-1 negatively regulates cytotrophoblast proliferation in first-trimester human placenta by modulating EGFR activation.

Authors:  Karen Forbes; Laura Skinner; John D Aplin; Melissa Westwood
Journal:  Cell Mol Life Sci       Date:  2012-07-15       Impact factor: 9.261

Review 8.  Roles of Vitamin A Metabolism in the Development of Hepatic Insulin Resistance.

Authors:  Guoxun Chen
Journal:  ISRN Hepatol       Date:  2013-09-30

9.  Inhibition of Src homology 2 domain-containing phosphatase 1 increases insulin sensitivity in high-fat diet-induced insulin-resistant mice.

Authors:  Janine Krüger; Ernst Wellnhofer; Heike Meyborg; Philipp Stawowy; Arne Östman; Ulrich Kintscher; Kai Kappert
Journal:  FEBS Open Bio       Date:  2016-01-04       Impact factor: 2.693

10.  α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitory Activity of Plastoquinones from Marine Brown Alga Sargassum serratifolium.

Authors:  Md Yousof Ali; Da Hye Kim; Su Hui Seong; Hyeung-Rak Kim; Hyun Ah Jung; Jae Sue Choi
Journal:  Mar Drugs       Date:  2017-12-01       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.